Cargando…
GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca(2+) channels
Glucagon is the body's main hyperglycemic hormone, and its secretion is dysregulated in type 2 diabetes mellitus (T2DM). The incretin hormone glucagon‐like peptide‐1 (GLP‐1) is released from the gut and is used in T2DM therapy. Uniquely, it both stimulates insulin and inhibits glucagon secretio...
Autores principales: | Ramracheya, Reshma, Chapman, Caroline, Chibalina, Margarita, Dou, Haiqiang, Miranda, Caroline, González, Alejandro, Moritoh, Yusuke, Shigeto, Makoto, Zhang, Quan, Braun, Matthias, Clark, Anne, Johnson, Paul R., Rorsman, Patrik, Briant, Linford J. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125244/ https://www.ncbi.nlm.nih.gov/pubmed/30187652 http://dx.doi.org/10.14814/phy2.13852 |
Ejemplares similares
-
CPT1a-Dependent Long-Chain Fatty Acid Oxidation Contributes to Maintaining Glucagon Secretion from Pancreatic Islets
por: Briant, Linford J.B., et al.
Publicado: (2018) -
Glucagon secretion from pancreatic α-cells
por: Briant, Linford, et al.
Publicado: (2016) -
Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019) -
Membrane Potential-Dependent Inactivation of Voltage-Gated Ion Channels in α-Cells Inhibits Glucagon Secretion From Human Islets
por: Ramracheya, Reshma, et al.
Publicado: (2010) -
Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production
por: Knudsen, Jakob G., et al.
Publicado: (2019)